Clinical Trial

Method Comparison of Intelligent Fingerprinting Drug Screening System

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, multi-site, open-label, single- or double-dose, randomized, multi-site performance evaluation of accuracy of the Intelligent Fingerprinting Drug Screening System in the hands of intended users: "operators" and "donors."
Trial Details
NCT Number NCT07650136
Lead Sponsor Intelligent Bio Solutions Inc.
Conditions Drug Abuse Illicit
Enrollment 144 participants
Start Date 2026-06-02
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-03